Member Info for rebarm

"Rather bizzerly, while SkinBioTherapeutics shares close lower, Croda international ganis 8p adding c£50m to the value of the company on the back of todays announcement." Courtesy of the Lemming Investors blog. Is this a speculative opinion or based on fact? Also OPTI is not the parent company of SBTX as you suggest in your blog. It is a shareholder albeit a major one!

A thoroughly disgusting post!

Ok Sheltie going by your number of posts you know much more than I do when it comes to investment and market plays but are you suggesting that the US Army is just having a punt?! Are they really going to be working with a company that is dead? Yes, it's certainly close to death's door but hasn't yet crossed the threshold otherwise the US Army and Government wouldn't have invested in this or would they?

Kettle, don't be ridiculous! If it was just about the delivery device they could fill it with water. This is the first, albeit small, piece of good news we've had from MTFB for too long so consider the implications for company and Iclaprim

Well I'm not giving up!! First letter s and fourth g!!

****ging. Not my choice but LSE's odd policing. Substitute '****' for the ****. I think highly appropriate and not in the least bit offensive. Clearly others have a different interpretation!

Hasiba, nicely put. Most corporates in their arrogance assume that us 'little people' will have a good whinge but do little else. Evidenced time and time again in the complaints pages of the financial media. Yes, 250 is a tad boring but whether we like it or not has probably been closer to the truth than even well researched LTHs.

Firstly we need an outcome. No point in raising a complaint with the FCA or whoever at this juncture as they will only knock it into touch as MTFB is still in business (I won't attempt to define 'what business"!!). However, I believe that early research into a formal procedure would be time well spent. For example, what is a the procedure for a formal investigation into an AIM company. I don't know as it's the first time I've been in this situation. Once that's in hand then appropriate information can start to be gathered. Firstly, I would look very very closely at recent RNS wording. What has been published that hasn't been delivered in the manner suggested in that RNS; what contradictions have been published; what if any communications can be proven to be lies etc. etc.

If there are any LTHs interested in forming a group with an independent communication channel, not LSE!, I'd be happy to participate and contribute. Only though if it comprises serious individuals as I've zero tolerance of the ****ging off that is endemic on this and other boards.

Any interested parties out there?

Afternoon Elrico, I presume you include yourself in the moaners and whiners category given some of your comments about this advertorial?!

You will know as well as I do that no investment, particularly on AIM, is a permanent bed of roses with a performance graph showing a straight line up and to the right. Like most LTHs, even you I suspect, I've been very disappointed with the recent sp performance. Except for the nasties that have ruined the ADVFN board with abusive and uncorroborated posts, I think LTHs have in the main been extremely supportive throughout the life of this company. However, when the need arises, such as with this awful BioEnergiser campaign, then we are perfectly entitled to express a negative point of view. I think you should acknowledge this rather than your use of the somewhat spiteful choice of words, 'moaning and whining".

Also if I refer to your most recent blog of yesterday and point out that this so called test campaign is national as it was supposed to be in the Saturday national tabloid press (not in UK at moment so don't know which one or indeed if it appeared). It is therefore rather disingenuous to describe whatever is planned in the future as a national campaign as if it is entirely different from today's exercise which is also national!

Final observation and question! You conclude your post with, 'I won't mention the sums because you're-'re not interested in these type of quotes.' Where did that come from??

Hi Elrico, not sure if your post is aimed at me but still a response required. There is zero connection between Seed and Bioenergiser other than Seed using an Opti ingredient. Seed operates in a different world and is a class apart from Bioenergiser. Also not interested in your quotes about what Seed may or may not achieve as I am 100% confident in their go-to market strategy. With regards to Bioenergiser which is the issue being discussed, you test market feedback in a controlled environment not with the broad brush and thoroughly unprofessional approach being taken by them. All this will do is pee off potential customers. Looks like many of your forum regulars are in complete agreement.

For what it’s worth, I’m a lth of some years. I Invested here for many reasons, one of which was the professionalism of SOH. This is the first time I’ve questioned that decision criteria element. The Bioenergiser campaign is crap and in my opinion does/will do a lot more harm than good.

Hi Nozick, you beat me to it! I was going to add a post with Seed as the comparator.

I'm sure a totally different market is being targeted by Seed but they launched with a clear, planned and superbly designed campaign. No live testing of marketing/advertising options which in my opinion is thoroughly unprofessional.

The biggest worry is that the Bioenergiser campaign, if you can call it that, strongly suggests that they don't actually know much, if anything, about the company and products they are supposed to be selling otherwise they would have launched with a professional equivalent of Seed although clearly shaped to suit what will be a different market. Overweight, Saturday tabloid consumers are somewhat different to the cool of East/West coast USA!! I will watch this campaign with interest!

Elrico, Thanks for posting but to be honest I'm very disappointed with these efforts from Bioenergiser.

For starters, any marketing organisation worth their salt would have tested before launch rather than this trial and error approach which inevitably will turn off segments of the addressable market.

Next, using Steve Thompson as brand ambassador is very strange. Yes, he's clearly overweight but other than rugby fans of a certain vintage who the heck remembers or has heard of him? Not many.

The ad scheduled to go out in the saturday press in my opinion cheapens the brand image. It's downmarket to say the least and is no different from most of the ads in the weekend tabloid press - cramped noise. Opti is head and shoulders above any competition (personally I don't think there is any) so why not create an image that reflects that. All in all very disappointing and, IMO, a missed opportunity.

Keep up shandy! NHS spends £600m+ per annum on OTC products for minor ailments. For example, glucosamine for joint aches. Much cheaper for individuals to buy themselves rather than troubling the NHS. Something like LPLDL, whilst a supplement, has medical benefits so could easily be prescribed by a GP. I'm promoting Opti in my local health centre but still to convince that it is an alternative to statins despite compelling evidence!!

Well said Ivy! Not what was hoped for but we live to fight another day which is more than can be said for a lot of unfortunate people who might have benefited from Iclaprim

Belgrano, reference your question below about sales suggest you check out RNS 7th May about LPLDL agreement with Capsa in Spain. I can confirm product under the brand 39ytu has been on the shelves in Spain for a number of months through both health food outlets and pharmacies. Product is COL-15-FRESA. It is also available through El Corte Ingles, the Spanish equivalent of John Lewis/Waitrose although I don't know if the same brand.

For what it's worth, the brand name 39ytu comes from us apparently having 39 billion bacteria in our guts!!
https://www.capsafood.com/nutraingredientes-awards/

...and don't forget the first name, Adrain McBain, who, along with Cath O'Neill, discovered the SBTX technology. He is also a major shareholder in SBTX with a 3.3% holding.

Perhaps getting carried away here, but apart from the Unilever contingent they are all academics with no commercial interests. Whilst our pair clearly have a deep scientific knowledge to contribute, they also happen to have developed, tested and trialled a product formulation!

Jamesrs1. Posted Sunday on ADVFN by manc10. An excellent find. Worth reading if only for the attendees.
https://www.ncbi.nlm.nih.gov/pubmed/31366612

Don't think so Kettle. Park Lane been mentioned on a number of occasions. Suspect it's all part of his sad little effort to wind up investors by suggesting that GL is living the good life......at our expense!

Bermudashorts - brilliant, brilliant and even more brilliant! Nice to see some humour amongst the OTT seriousness

SP250, I'm a LTH of MTFB and added significantly post Feb 14th. Averaging down or adding at a cheap price....who knows! My decision to invest in the first instance and add subsequently has been based on the best research I can access and I am happy with my investment decision albeit, at this stage, it remains high risk. I've had a no problem with most of your posts as, despite the recent pathetic antics of our parliamentary process, we still live in a democratic society and you are perfectly entitled to your point of view as long as it is objective. The problem I have had, however, with your posts, which is I suspect the problem with most of the anti SP250 commentary, is that you are threatening a decision making process which is based on many hours research (in my case anyway!!!!) with gross subjectivity.

Now, the primary purpose of this post was in response to your post about GL's interview and it was pleasing to see some positive commentary given your negativity towards GL. I am pleased that you have taken this view which to me suggests that you are perhaps more objective than the criticism aimed at you might suggest. I have just watched the interview and given the current circumstances was very impressed with GL both in terms of interview content and delivery style. I have met GL on a number of occasions, unlike you I suspect, and have found him very approachable and as open as circumstances allow. I think he is as open and honest as any CEO can be. Indeed, one of my key investment criteria is personnel. You might like to attend an investment forum and take advantage of that for a 1 on 1 with GL which I suspect might influence your point of view.

In the meantime, keep posting but please drop the offensive commentary. It is unnecessary!

......or the FDA or the Sackler family's fault!